Suppr超能文献

编码一种C-糖基转移酶的gilGT和编码一种细胞色素P450酶的gilOIII的失活,使得吉尔vocarcin V后期生物合成途径的细节得以阐明。

Inactivation of gilGT, encoding a C-glycosyltransferase, and gilOIII, encoding a P450 enzyme, allows the details of the late biosynthetic pathway to gilvocarcin V to be delineated.

作者信息

Liu Tao, Kharel Madan Kumar, Fischer Carsten, McCormick Andrew, Rohr Jürgen

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, 40536-0082, USA.

出版信息

Chembiochem. 2006 Jul;7(7):1070-7. doi: 10.1002/cbic.200600031.

Abstract

Resequencing of the gilGT gene, which encodes a putative glycosyltransferase (GT) that is 495 amino acids (aa) long, from the Streptomyces griseoflavus Gö3592 gilvocarcin V (GV) gene cluster, revealed that the previously reported gilGT indeed contains two genes. These are the larger gilGT, which encodes the C-glycosyltransferase GilGT (379 aa), and the smaller gilV gene, which encodes an enzyme of unknown function (116 aa). The gene gilV is located immediately upstream of gilGT in the GV gene cluster. In-frame deletion of gilGT created a mutant that accumulated defucogilvocarcin E (defuco-GE). The result proves the function of GilGT as a C-glycosyltransferase. Deletion of gilOIII, which is located immediately downstream of gilGT, led to a mutant that accumulated gilvocarcin E (GE). This confirms that the corresponding P450 enzyme, GilOIII, is involved in the vinyl-group formation of GV. Cross-feeding experiments in which GE, defuco-GE, and defucogilvocarcin V (defuco-GV) were fed to an early blocked mutant of the GV biosynthetic pathway, showed that neither GE nor any of the defuco- compounds was an intermediate of the pathway.

摘要

对来自灰黄链霉菌Gö3592的吉尔vocarcin V(GV)基因簇中编码一种推定的糖基转移酶(GT)(长495个氨基酸(aa))的gilGT基因进行重测序,结果显示先前报道的gilGT实际上包含两个基因。其中较大的gilGT编码C-糖基转移酶GilGT(379个aa),较小的gilV基因编码一种功能未知的酶(116个aa)。gilV基因位于GV基因簇中gilGT的紧邻上游。gilGT的框内缺失产生了一个积累去糖基吉尔vocarcin E(去糖基-GE)的突变体。该结果证明了GilGT作为C-糖基转移酶的功能。gilGT紧邻下游的gilOIII缺失导致一个积累吉尔vocarcin E(GE)的突变体。这证实了相应的细胞色素P450酶GilOIII参与了GV的乙烯基形成。将GE、去糖基-GE和去糖基吉尔vocarcin V(去糖基-GV)喂给GV生物合成途径早期受阻突变体的交叉饲养实验表明,GE和任何一种去糖基化合物都不是该途径的中间体。

相似文献

引用本文的文献

4
OleD Loki as a Catalyst for Hydroxamate Glycosylation.奥列·洛基(OleD Loki)作为羟肟酸糖基化的催化剂。
Chembiochem. 2020 Apr 1;21(7):952-957. doi: 10.1002/cbic.201900601. Epub 2019 Nov 26.

本文引用的文献

2
'Sweetening' natural products via glycorandomization.通过糖基随机化对天然产物进行“甜味化”。
Curr Opin Biotechnol. 2005 Dec;16(6):622-30. doi: 10.1016/j.copbio.2005.10.002. Epub 2005 Oct 13.
3
Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.通过新糖基随机化增强强心苷的抗癌特性。
Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12305-10. doi: 10.1073/pnas.0503270102. Epub 2005 Aug 16.
4
In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase.病原体相关的C-糖基转移酶IroB的体外特性研究
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):571-6. doi: 10.1073/pnas.0408463102. Epub 2004 Dec 14.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验